Psyence, Newcourt Deal Would Create New Palliative Care Psychedelics Company
Hospice News
JANUARY 10, 2023
billion by 2027, up from $2 billion in 2020. A new, publicly traded company devoted to exploring the use of psychedelics in palliative care is in development. Psyence Biomed, a subsidiary of the Canadian biotech company Psyence Group Inc.,
Let's personalize your content